Sex- and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan

JAMA Ophthalmology

Volumn 132, Issue 8, 2014, Pages 922-928

  Lin, Jen Chieh ^a,b   Shau, Wen Yi ^c   Lai, Mei Shu ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DIABETIC RETINOPATHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SIGHT THREATENING DIABETIC RETINOPATHY; TAIWAN;

AGE FACTORS; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; MACULAR EDEMA; MALE; PREVALENCE; SEX CHARACTERISTICS; TAIWAN;

EID: 84907343734     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2014.859     Document Type: Article

References (43)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844-851.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28(suppl 1):S37-S42.
4. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787.
5. Støvring H, Andersen M, Beck-Nielsen H, Green A, VachW. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet. 2003;362(9383):537-538.
6. Thomas RJ, Palumbo PJ, Melton LJ III, et al. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester,Minn, 1970-1994. Arch Intern Med. 2003;163(4):445-451.
7. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
8. Katzmarzyk PT, Mason C. Prevalence of class I, II and III obesity in Canada. CMAJ. 2006;174(2):156-157.
9. Rennie KL, Jebb SA. Prevalence of obesity in Great Britain. Obes Rev. 2005;6(1):11-12.
10. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26(4):1258- 1264.
11. Kempen JH, O'Colmain BJ, Leske MC, et al; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4): 552-563.
12. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J; Linköping Diabetes Complications Study. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes - the Linköping Diabetes Complications Study. Diabetologia. 2004;47(7):1266-1272.
13. Sloan FA, Belsky D, Ruiz D Jr, Lee P. Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005. Arch Ophthalmol. 2008;126(11):1548-1553.
14. Klein R, Klein BE. Are individuals with diabetes seeing better? a long-term epidemiological perspective. Diabetes. 2010;59(8):1853-1860.
15. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005;46(7):2328-2333.
16. Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141(3):446-455.
17. Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009;116(3):461-467.
18. Scanlon PH. The preferences of people with diabetes for diabetic retinopathy screening. Diabet Med. 2012;29(7):836-837.
19. Tapp RJ, Shaw JE, Harper CA, et al; AusDiab Study Group. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26(6): 1731-1737.
20. Roy MS, Klein R, O'Colmain BJ, Klein BE, Moss SE, Kempen JH. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol. 2004;122(4): 546-551.
21. Wong TY, Cheung N, TayWT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008; 115(11):1869-1875.
22. Cheung N,Mitchell P,Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124-136.
23. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227-1239.
24. Chen MS, Kao CS, Chang CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol. 1992;114(6):723-730.
25. Tsai MT,Woung LC, Tsai WH, et al. Healthcare utilization by patients with diabetes and diabetic retinopathy among National Health Insurance enrollees in Taiwan. Taiwan J Public Health. 2008; 27(2):101-109.
26. Chang CH, ShauWY, Jiang YD, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a National Health Insurance data set study. Diabet Med. 2010;27(6): 636-643.
27. Klein R. Prevention of visual loss from diabetic retinopathy. Surv Ophthalmol. 2002;47(suppl 2): S246-S252.
28. Wen CP, Tsai SP, ChungWS. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med. 2008;148(4):258-267.
29. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1: Early Treatment Diabetic Retinopathy Study research Group. Arch Ophthalmol. 1985;103 (12):1796-1806.
30. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report No. 4. Int Ophthalmol Clin. 1987;27(4):265-272.
31. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology. 1981;88(7):583-600.
32. Yau JW, Rogers SL, Kawasaki R, et al; Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3): 556-564.
33. Wong TY, Mwamburi M, Klein R, et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-Analysis. Diabetes Care. 2009;32(12):2307-2313.
34. Weitzman S, Greenfield S, Billimek J, et al. Improving combined diabetes outcomes by adding a simple patient intervention to physician feedback: a cluster randomized trial. Isr Med Assoc J. 2009;11 (12):719-724.
35. Elis A, Rosenmann L, Chodick G, Heymann AD, Kokia E, Shalev V. The association between glycemic, lipids and blood pressure control among Israeli diabetic patients. QJM. 2008;101(4):275-280.
36. Chew EY, Ferris FL III, Csaky KG, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the Early Treatment Diabetic Retinopathy follow-up study. Ophthalmology. 2003;110(9):1683-1689.
37. Weng RH, Shiu RS, Hsieh YC. Current status of diabetes shared care in Taiwan. Formos J Med. 2002;6:569-573.
38. Tseng FY, Lai MS, Syu CY, Lin CC. Professional accountability for diabetes care in Taiwan. Diabetes Res Clin Pract. 2006;71(2):192-201.
39. Bailey RN, Indian RW, Zhang X, Geiss LS, Duenas MR, Saaddine JB; Centers for Disease Control and Prevention. Visual impairment and eye care among older adults - five states, 2005. MMWR Morb Mortal Wkly Rep. 2006;55(49):1321-1325.
40. Lee DJ, Lam BL, Arora S, et al. Reported eye care utilization and health insurance status among US adults. Arch Ophthalmol. 2009;127(3):303-310.
41. Krämer HU, Rüter G, Schöttker B, et al. Gender differences in healthcare utilization of patients with diabetes. Am J Manag Care. 2012;18(7):362-369.
42. Caro JJ, Ward AJ, O'Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the US. Diabetes Care. 2002;25(3):476-481.
43. JamesM, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000;320(7250):1627-1631.